127 related articles for article (PubMed ID: 12695169)
41. Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
Ruiz-Jimeno T; Carvajal A; Mata C; Aurrecoechea E
J Rheumatol; 2006 Jul; 33(7):1457-8. PubMed ID: 16862660
[No Abstract] [Full Text] [Related]
42. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study.
Mazzanti G; Coloni L; De Sabbata G; Paladini G
Acta Derm Venereol Suppl (Stockh); 1994; 186():116-7. PubMed ID: 8073808
[No Abstract] [Full Text] [Related]
44. Amyotrophic lateral sclerosis developing during adalimumab therapy for psoriatic arthritis.
Bougea A; Anagnostou E; Stamboulis E; Kararizou E
Rev Neurol (Paris); 2014 Mar; 170(3):228-9. PubMed ID: 24656415
[No Abstract] [Full Text] [Related]
45. Termination of disease modifying antirheumatic drugs in psoriatic arthritis.
Ujfalussy I; Koó E; Seszták M
J Rheumatol; 2001 Mar; 28(3):682-3. PubMed ID: 11296986
[No Abstract] [Full Text] [Related]
46. Acute generalized skin eruption due to adalimumab: report of two cases.
Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
[No Abstract] [Full Text] [Related]
47. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Lynch M; Kirby B
Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
[No Abstract] [Full Text] [Related]
48. Occurrence of penile intraepithelial neoplasia following adalimumab treatment for psoriatic arthritis.
Kreuter A; Meyer MF; Wieland U
Arch Dermatol; 2011 Aug; 147(8):1001-2. PubMed ID: 21844477
[No Abstract] [Full Text] [Related]
49. [Spondyloarthritis including psoriatic arthritis].
Krause A; Märker-Hermann E
Dtsch Med Wochenschr; 2012 Oct; 137(40):2031-3. PubMed ID: 23023616
[No Abstract] [Full Text] [Related]
50. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
[TBL] [Abstract][Full Text] [Related]
51. Methotrexate in psoriatic arthritis.
Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
[TBL] [Abstract][Full Text] [Related]
52. Author reply: To PMID 25442759.
Commons RJ; Hannah R; Currie BJ
Intern Med J; 2015 May; 45(5):591. PubMed ID: 25955472
[No Abstract] [Full Text] [Related]
53. Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment.
Raffayová H; Rovenský J; Mális F
Int J Clin Pharmacol Res; 2000; 20(1-2):1-11. PubMed ID: 11146896
[TBL] [Abstract][Full Text] [Related]
54. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
[TBL] [Abstract][Full Text] [Related]
55. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
[TBL] [Abstract][Full Text] [Related]
56. Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature.
Mourão AF; Rustin M; Isenberg D
Clin Exp Rheumatol; 2010; 28(3):408-10. PubMed ID: 20576227
[TBL] [Abstract][Full Text] [Related]
57. Not only monoclonal antibodies..
Nossent JC
Intern Med J; 2015 May; 45(5):590. PubMed ID: 25955470
[No Abstract] [Full Text] [Related]
58. Early psoriatic arthritis.
Gladman DD
Rheum Dis Clin North Am; 2012 May; 38(2):373-86. PubMed ID: 22819090
[TBL] [Abstract][Full Text] [Related]
59. Hyperpigmentation of the face following adalimumab treatment.
Blomberg M; Zachariae CO; Grønhøj F
Acta Derm Venereol; 2009; 89(5):546-7. PubMed ID: 19734995
[No Abstract] [Full Text] [Related]
60. Cyclosporine in psoriatic arthropathy.
Soriano A; Pipitone N; Salvarani C
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S101-3. PubMed ID: 26470797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
